[
  {
    "ts": null,
    "headline": "Medtronic to announce financial results for its first quarter of fiscal year 2026",
    "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025,",
    "url": "https://finnhub.io/api/news?id=bd572aa020bcfa8aab9171c5bf4fe8ab9a96318f498b90c2fe6a29afeb95aabc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754429280,
      "headline": "Medtronic to announce financial results for its first quarter of fiscal year 2026",
      "id": 136232424,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025,",
      "url": "https://finnhub.io/api/news?id=bd572aa020bcfa8aab9171c5bf4fe8ab9a96318f498b90c2fe6a29afeb95aabc"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Reports for Morgan Stanley, PepsiCo & Comcast",
    "summary": "MS rides strong trading gains and wealth focus, while PEP and CMCSA wrestle with demand and subscriber shifts.",
    "url": "https://finnhub.io/api/news?id=7bfd7693212dcc777efa780069743c9a70ab76bd0f94bed021d2e39773cdc85c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754422140,
      "headline": "Top Stock Reports for Morgan Stanley, PepsiCo & Comcast",
      "id": 136232324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "MS rides strong trading gains and wealth focus, while PEP and CMCSA wrestle with demand and subscriber shifts.",
      "url": "https://finnhub.io/api/news?id=7bfd7693212dcc777efa780069743c9a70ab76bd0f94bed021d2e39773cdc85c"
    }
  },
  {
    "ts": null,
    "headline": "Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again",
    "summary": "Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=ae0f17107406df7d091669a516746bfdee933e3525bb4ba6cc4a677b48a1bf5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754410201,
      "headline": "Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again",
      "id": 136215066,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=ae0f17107406df7d091669a516746bfdee933e3525bb4ba6cc4a677b48a1bf5c"
    }
  },
  {
    "ts": null,
    "headline": "United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka",
    "summary": "The United States Smart Pills Market is set to grow significantly, reaching US$ 4.13 billion by 2033, up from US$ 1.53 billion in 2024, with a CAGR of 11.66% from 2025 to 2033. Driving forces include rising demand for minimally invasive diagnostics, a surge in gastrointestinal disorders, an aging population, and advancements in wireless capsule technology. As telemedicine integrates smart pills, enhanced patient care and monitoring are expected. However, challenges like high technology costs and",
    "url": "https://finnhub.io/api/news?id=bfdf2c9b572dfbe77c17d34a6a3400fea33634b05368e281e3b8c10b51bae10d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754399160,
      "headline": "United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka",
      "id": 136212278,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The United States Smart Pills Market is set to grow significantly, reaching US$ 4.13 billion by 2033, up from US$ 1.53 billion in 2024, with a CAGR of 11.66% from 2025 to 2033. Driving forces include rising demand for minimally invasive diagnostics, a surge in gastrointestinal disorders, an aging population, and advancements in wireless capsule technology. As telemedicine integrates smart pills, enhanced patient care and monitoring are expected. However, challenges like high technology costs and",
      "url": "https://finnhub.io/api/news?id=bfdf2c9b572dfbe77c17d34a6a3400fea33634b05368e281e3b8c10b51bae10d"
    }
  },
  {
    "ts": null,
    "headline": "Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings",
    "summary": "$56.2 million in proceeds from completed public offering and concurrent private equity purchase by Medtronic and Ligand$55 million in proceeds and funding commitments from royalty-based, non-dilutive investments from Medtronic and LigandProceeds extend expected cash runway into the second half of 2027 and expected to fund completion of enrollment and follow up for the primary endpoint of the BACKBEAT study, as well as substantial enrollment of the Virtue Trial NEW HOPE, Pa., Aug. 05, 2025 (GLOBE",
    "url": "https://finnhub.io/api/news?id=91cab7d0ba6e8bdb69287be4f6aa94f73b065e2a3c07819b55cf4033e8b6c432",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391600,
      "headline": "Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings",
      "id": 136212464,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "$56.2 million in proceeds from completed public offering and concurrent private equity purchase by Medtronic and Ligand$55 million in proceeds and funding commitments from royalty-based, non-dilutive investments from Medtronic and LigandProceeds extend expected cash runway into the second half of 2027 and expected to fund completion of enrollment and follow up for the primary endpoint of the BACKBEAT study, as well as substantial enrollment of the Virtue Trial NEW HOPE, Pa., Aug. 05, 2025 (GLOBE",
      "url": "https://finnhub.io/api/news?id=91cab7d0ba6e8bdb69287be4f6aa94f73b065e2a3c07819b55cf4033e8b6c432"
    }
  }
]